bearish•CanSino Biologics •26 Jul 2023 08:55
CanSino Biologics (6185.HK/688185.CH) - The Story Has Changed
MCV4's sales could be sluggish this year, so CanSino's investment logic has completely changed.Due to a lack of potential to become a great vaccine...
bullish•CanSino Biologics •09 Jun 2021 09:15
CanSino Biologics (688185.CH/6185.HK) - Time for Corner Overtaking?
The inhaled COVID-19 vaccine of CanSino is applying for emergency use in China,which worth the attention of investors.The article analyzed the...
bullish•CanSino Biologics •05 Feb 2023 09:27
China Healthcare Weekly (Feb.3)- CanSino, Blood Products Shortage, Don't Be Greedy in Front of Rally
Contradiction between blood products supply and demand is intensifying. Cansino plans to IPO in Swiss -We see upside potential in...
bullish•CanSino Biologics •19 Oct 2022 08:51
CanSino Biologics Inc (688185.CH/6185.HK) - Some Positive Progress in Business
Cansino has made positive progress in commercialization and R&D recently. We look forward to the performance of MCV4 in H2. Its valuation in HKEX...
bullish•Ninebot •21 Apr 2021 09:59